نتائج لـ (((((("per decrease") OR ("used decrease"))) OR ("sir decrease"))) OR ("mean decrease"))*

نتائج لـ (((((("per decrease") OR ("used decrease"))) OR ("sir decrease"))) OR ("mean decrease"))* يعرض 1 - 8 نتائج من 8 Laminas_Feed_Writer 2 (https://getlaminas.org) https://asren-aggregator.asren.net/Search/Results?sort=last_indexed+desc&limit=50&lookfor=%28%28%28%28%28%28%22per+decrease%22%29+OR+%28%22used+decrease%22%29%29%29+OR+%28%22sir+decrease%22%29%29%29+OR+%28%22mean+decrease%22%29%29%2A&type=AllFields&lng=ar 8 0 50 Role of intravitreal antivascular endothelial growth factor injections for choroidal neovascularization due to choroidal osteoma Wed, 01 Jan 2014 16:46:31 -0500 https://asren-aggregator.asren.net/Record/LAURepo_07c1f1bef674b7cfef072417e737eb0a https://asren-aggregator.asren.net/Record/LAURepo_07c1f1bef674b7cfef072417e737eb0a Mansour, Ahmad M. article 2014 Mansour, Ahmad M. 0 Cryomyolysis, a new procedure for the conservative treatment of uterine fibroids Thu, 01 Jan 1998 16:46:31 -0500 https://asren-aggregator.asren.net/Record/LAURepo_90e9b3d425f1f0d4343414d514697f74 https://asren-aggregator.asren.net/Record/LAURepo_90e9b3d425f1f0d4343414d514697f74 Zreik, Tony article 1998 Zreik, Tony 0 Tranexamic Acid Application in Facial Aesthetic Surgery: An Umbrella Review Mon, 01 Jan 2024 16:46:31 -0500 https://asren-aggregator.asren.net/Record/Manara2_01a09dbc8aac71e5fc37ed80bdde2a2e https://asren-aggregator.asren.net/Record/Manara2_01a09dbc8aac71e5fc37ed80bdde2a2e Mohamed Badie Ahmed (10223510) 2024 Mohamed Badie Ahmed (10223510) 0 Does standalone phacoemulsification lower intraocular pressure in glaucomatous eyes? A systematic review and meta-analysis Wed, 01 Jan 2025 16:46:31 -0500 https://asren-aggregator.asren.net/Record/Manara2_0c7b9a67873220e71bac467e8589132b https://asren-aggregator.asren.net/Record/Manara2_0c7b9a67873220e71bac467e8589132b Osama Hussein (21301202) 2025 Osama Hussein (21301202) 0 Sleeve Gastrectomy in Patients with Type 2 Diabetes: Anthropometric and Cardiometabolic Improvements at 1, 3, 5, 7, and 9 years—Are the Initial Benefits Sustained? Wed, 01 Jan 2025 16:46:31 -0500 https://asren-aggregator.asren.net/Record/Manara2_80ac628290ae8745603f69e68490bd2b https://asren-aggregator.asren.net/Record/Manara2_80ac628290ae8745603f69e68490bd2b Wahiba Elhag (5245547) 2025 Wahiba Elhag (5245547) 0 A 5-year trend in the use of sodium-glucose co-transporter 2 inhibitors and other oral antidiabetic drugs in a Middle Eastern country Sat, 01 Jan 2022 16:46:31 -0500 https://asren-aggregator.asren.net/Record/Manara2_ab785aa637b3b14b28c0e374fe4719be https://asren-aggregator.asren.net/Record/Manara2_ab785aa637b3b14b28c0e374fe4719be Nancy Zaghloul (14147865) 2022 Nancy Zaghloul (14147865) 0 The cost-benefit associated with the maturity of the Antimicrobial Stewardship Program versus prematurity in Heart Hospital of Hamad Medical Corporation in Qatar Sun, 01 Jan 2023 16:46:31 -0500 https://asren-aggregator.asren.net/Record/Manara2_f2388fe4fd2f633a28de39666eeac653 https://asren-aggregator.asren.net/Record/Manara2_f2388fe4fd2f633a28de39666eeac653 Dina Abushanab (10696501) 2023 Dina Abushanab (10696501) 0 Spatial, temporal, and demographic patterns in prevalence of chewing tobacco use in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019 Fri, 01 Jan 2021 16:46:31 -0500 https://asren-aggregator.asren.net/Record/Manara2_fdbfc35452c891467c044ecd9acae404 https://asren-aggregator.asren.net/Record/Manara2_fdbfc35452c891467c044ecd9acae404 Parkes J Kendrick (9714851) 2021 Parkes J Kendrick (9714851) 0